Drugs in Neurology

Sathiji K Nageshwaran completed his medical training at University College London and doctoral work at Imperial College London, synthetic biology training in the lab of George Church at Harvard Medical School and residency in Neurology at Mount Sinai Hospital. He is currently a Neurogenetics Fellow at UCLA in the lab of Daniel Geschwind. David Ledingham completed his medical training at the University of Cambridge and University College London. He is currently a Consultant Neurologist at Newcastle Hospitals and is an Honorary Senior Lecturer at Newcastle University. His clinical interests include movement disorders, deep brain stimulation and botulinum toxin injections. He is actively involved in research and clinical trials in the fields of Parkinson's disease, atypical Parkinson's and dystonia. Dr Heather Wilson is a senior consultant neurologist who joined the MS team at the National Hospital for Neurology and Neurosurgery at UCL in 2020, after working as a general neurologist and MS specialist at the Royal Free NHS Foundation Trust for 16 years. She has experience in managing all aspects of Multiple Sclerosis including all of the licensed disease-modifying therapies, and is committed to MS service development and optimisation. She graduated from Guy's Hospital Medical School in 1990 and undertook her Neurology specialist training in London (King's College Hospital, NHNN and the Royal Free Hospital). She has a PhD in Neuro-immunology from Cambridge University and has an ongoing interest in the immunopathology of MS. She is nationally recognised in the field of MS and reglarly speaks on the topic at national and local levels.